Supplementary Fig. S9 from FAP-Targeted LTβR Agonist Drives HEV Differentiation and Immune Niche Formation for Improved Immunotherapy Response in Solid Tumors
Authors:Roberta Bianchi, Leo Kunz, Ralf J. Hosse et al.
<jats:p><p>Schematic detailing and results from the in vivo study with BC004 tumor model in humanized mice treated with FAP-LTBR and FolR1 TCB in monotherapy and in combination.</p></jats:p>
Keywords
pschematicdetailingresultsfromvivo
Related Articles
On the Impossibility of Deriving Quantitative Intra-Multiplet Splittings from Symmetry-Complete Dynamics Alone